Jan Bolinder

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Diabetologia

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes care

Karolinska Institutet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Jan 01 2004

Sweden

Professor :: Department of Medicine, Karolinska Huddinge

Publications

Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia 67 (8) (2024)
Sofia Sterner Isaksson, Henrik Imberg, Irl B Hirsch, Erik Schwarcz, Jarl Hellman, Magnus Olof Wijkman, Jan Bolinder, Thomas Nyström, Helene Holmer, Sara Hallström, Arndís Finna Ólafsdóttir, Sofia Pekkari, William Polonsky, Marcus Lind
Discordance between mean glucose and time in range in relation to HbA 1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia (2024)
Marcus Lind, Sergiu-Bogdan Catrina, Neda Rajamand Ekberg, Sofia Gerward, Tariq Halasa, Jarl Hellman, Detlef Hess, Magnus Löndahl, Veronica Qvist, Jan Bolinder
Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Marcus Lind, Arndís Finna Ólafsdóttir, Irl B Hirsch, Jan Bolinder, Sofia Dahlqvist, Aldina Pivodic, Jarl Hellman, Magnus Wijkman, Erik Schwarcz, Henrik Albrektsson, Tim Heise, William H Polonsky
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI. Diabetes care 44 (1) (2020)

Jan Bolinder.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jan Bolinder